Back

COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021

de Gier, B.; Kooijman, M.; Kemmeren, J.; de Keizer, N.; Dongelmans, D.; van Iersel, S. C. J. L.; van de Kassteele, J.; Andeweg, S. P.; the RIVM COVID-19 epidemiology and surveillance team, ; de Melker, H. E.; Hahne, S. J. M.; Knol, M. J.; van den Hof, S.

2021-09-17 infectious diseases Community evaluation
10.1101/2021.09.15.21263613 medRxiv
Show abstract

The objective of this study was to estimate vaccine effectiveness (VE) against COVID-19 hospitalization and ICU admission, per period according to dominating SARS-CoV-2 variant (Alpha and Delta), per vaccine and per time since vaccination. To this end, data from the national COVID-19 vaccination register was added to the national register of COVID-19 hospitalizations. For the study period 4 April - 29 August 2021, 15,571 hospitalized people with COVID-19 were included in the analysis, of whom 887 (5.7%) were fully vaccinated. Incidence rates of hospitalizations and ICU admissions per age group and vaccination status were calculated, and VE was estimated as 1-incidence rate ratio, adjusted for calendar date and age group in a negative binomial regression model. VE against hospitalization for full vaccination was 94% (95%CI 93-95%) in the Alpha period and 95% (95%CI 94-95%) in the Delta period. The VE for full vaccination against ICU admission was 93% (95%CI 87-96%) in the Alpha period and 97% (95%CI 97-98%) in the Delta period. VE was high in all age groups and did not show waning with time since vaccination up to 20 weeks after full vaccination.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Eurosurveillance
● 83 papers in training set
Top 0.1%
30.4%
Similar papers in this journal
2
Vaccine
○ 203 papers in training set
Top 0.4%
9.6%
Similar papers in this journal
3
Vaccines
○ 198 papers in training set
Top 0.5%
6.1%
Similar papers in this journal
4
International Journal of Infectious Diseases
○ 129 papers in training set
Top 0.2%
6.1%
Similar papers in this journal
50% of probability mass above
5
PLOS ONE
● 5266 papers in training set
Top 28%
5.4%
Similar papers in this journal
6
BMJ
● 51 papers in training set
Top 0.1%
4.7%
7
The Lancet Infectious Diseases
○ 73 papers in training set
Top 0.3%
3.4%
8
Clinical Microbiology and Infection
○ 62 papers in training set
Top 0.1%
3.2%
9
BMC Medicine
○ 176 papers in training set
Top 2%
2.1%
10
Clinical Infectious Diseases
◐ 235 papers in training set
Top 2%
1.5%
11
PLOS Medicine
● 110 papers in training set
Top 2%
1.3%
12
Open Forum Infectious Diseases
◐ 142 papers in training set
Top 2%
1.1%
13
Infectious Diseases and Therapy
○ 18 papers in training set
Top 0.2%
1.1%
14
Emerging Infectious Diseases
● 105 papers in training set
Top 1%
1.1%
15
New England Journal of Medicine
● 52 papers in training set
Top 0.4%
1.1%
16
Scientific Reports
○ 3612 papers in training set
Top 65%
1.1%
17
Nature Communications
○ 5641 papers in training set
Top 52%
1.0%
18
BMC Infectious Diseases
○ 133 papers in training set
Top 4%
1.0%
19
Infectious Diseases
○ 14 papers in training set
Top 0.1%
1.0%
20
The Lancet Regional Health - Americas
○ 22 papers in training set
Top 0.7%
0.8%
21
The Lancet Regional Health - Europe
○ 33 papers in training set
Top 0.6%
0.8%
22
BMJ Open
● 601 papers in training set
Top 12%
0.8%
23
European Journal of Epidemiology
○ 43 papers in training set
Top 0.8%
0.8%
24
Frontiers in Medicine
○ 120 papers in training set
Top 4%
0.8%
25
Epidemiology and Infection
◐ 89 papers in training set
Top 3%
0.8%
26
Journal of Infection
○ 78 papers in training set
Top 1%
0.8%
27
Human Vaccines & Immunotherapeutics
○ 25 papers in training set
Top 0.6%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.